Boston Scientific to participate in TD Cowen's 45th Annual Health Care Conference
Boston Scientific (NYSE: BSX) has announced its participation in TD Cowen's 45th Annual Health Care Conference scheduled for March 4, 2025. The company will be represented by three key executives: Dan Brennan (Executive VP and CFO), Art Butcher (Executive VP and Group President, MedSurg and Asia Pacific), and Dr. Kenneth Stein (Senior VP and Chief Medical Officer).
The executives will engage in a 30-minute fireside chat with the host analyst, beginning at approximately 9:10 a.m. ET. The session will be available via live webcast, with a replay accessible on the company's investor relations website approximately one hour after the event concludes.
Boston Scientific (NYSE: BSX) ha annunciato la sua partecipazione alla 45ª Conferenza Annuale sulla Salute di TD Cowen in programma per il 4 marzo 2025. L'azienda sarà rappresentata da tre dirigenti chiave: Dan Brennan (Vice Presidente Esecutivo e CFO), Art Butcher (Vice Presidente Esecutivo e Presidente del Gruppo, MedSurg e Asia Pacifico) e Dr. Kenneth Stein (Vice Presidente Senior e Direttore Medico).
I dirigenti parteciperanno a un chat informale di 30 minuti con l'analista ospitante, che avrà inizio approssimativamente alle 9:10 a.m. ET. La sessione sarà disponibile tramite webcast dal vivo, con una registrazione accessibile sul sito web delle relazioni con gli investitori dell'azienda circa un'ora dopo la conclusione dell'evento.
Boston Scientific (NYSE: BSX) ha anunciado su participación en la 45ª Conferencia Anual de Salud de TD Cowen programada para el 4 de marzo de 2025. La empresa estará representada por tres ejecutivos clave: Dan Brennan (Vicepresidente Ejecutivo y CFO), Art Butcher (Vicepresidente Ejecutivo y Presidente del Grupo, MedSurg y Asia Pacífico) y Dr. Kenneth Stein (Vicepresidente Senior y Director Médico).
Los ejecutivos participarán en una charla informal de 30 minutos con el analista anfitrión, que comenzará aproximadamente a las 9:10 a.m. ET. La sesión estará disponible a través de un webcast en vivo, con una repetición accesible en el sitio web de relaciones con inversores de la empresa aproximadamente una hora después de que concluya el evento.
Boston Scientific (NYSE: BSX)는 TD Cowen의 제45회 연례 의료 회의에 참석한다고 발표했습니다. 이 회의는 2025년 3월 4일에 예정되어 있습니다. 회사는 세 명의 주요 임원에 의해 대표됩니다: Dan Brennan (Executive VP 및 CFO), Art Butcher (Executive VP 및 MedSurg 및 아시아 태평양 그룹 회장), Dr. Kenneth Stein (Senior VP 및 최고 의료 책임자).
임원들은 호스트 분석가와 함께 30분 간의 대화에 참여할 예정이며, 대화는 약 오전 9시 10분 ET에 시작됩니다. 이 세션은 실시간 웹캐스트를 통해 제공되며, 이벤트 종료 약 1시간 후에 회사의 투자자 관계 웹사이트에서 재생할 수 있습니다.
Boston Scientific (NYSE: BSX) a annoncé sa participation à la 45e Conférence Annuelle sur la Santé de TD Cowen prévue pour le 4 mars 2025. L'entreprise sera représentée par trois dirigeants clés : Dan Brennan (Vice-Président Exécutif et CFO), Art Butcher (Vice-Président Exécutif et Président du Groupe, MedSurg et Asie-Pacifique) et Dr. Kenneth Stein (Vice-Président Senior et Médecin-Chef).
Les dirigeants participeront à une discussion informelle de 30 minutes avec l'analyste hôte, qui commencera vers 9h10 ET. La session sera disponible via un webcast en direct, avec une rediffusion accessible sur le site web des relations investisseurs de l'entreprise environ une heure après la fin de l'événement.
Boston Scientific (NYSE: BSX) hat seine Teilnahme an der 45. jährlichen Gesundheitskonferenz von TD Cowen angekündigt, die für den 4. März 2025 geplant ist. Das Unternehmen wird durch drei Schlüsselmitarbeiter vertreten: Dan Brennan (Executive VP und CFO), Art Butcher (Executive VP und Gruppenpräsident, MedSurg und Asien-Pazifik) und Dr. Kenneth Stein (Senior VP und Chief Medical Officer).
Die Führungskräfte werden an einem 30-minütigen Gespräch mit dem Gastgeberanalysten teilnehmen, das voraussichtlich um 9:10 Uhr ET beginnt. Die Sitzung wird live über einen Webcast verfügbar sein, mit einer Wiederholung, die etwa eine Stunde nach Abschluss der Veranstaltung auf der Investor-Relations-Website des Unternehmens zugänglich ist.
- None.
- None.
Dan Brennan, executive vice president and chief financial officer, Art Butcher, executive vice president and group president, MedSurg and
About Boston Scientific
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 45 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of health care. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. Learn more at www.bostonscientific.com and connect on LinkedIn and X, formerly Twitter.
CONTACTS:
Chanel Hastings
Media Relations
+1 (508) 382-0288
Chanel.Hastings@bsci.com
Jon Monson
Investor Relations
+1 (508) 683-5450
BSXInvestorRelations@bsci.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/boston-scientific-to-participate-in-td-cowens-45th-annual-health-care-conference-302378128.html
SOURCE Boston Scientific Corporation
FAQ
When is Boston Scientific (BSX) presenting at TD Cowen's Healthcare Conference 2025?
Which Boston Scientific (BSX) executives are participating in TD Cowen's 2025 Healthcare Conference?
How long will Boston Scientific's (BSX) presentation be at the TD Cowen Healthcare Conference?
How can investors access Boston Scientific's (BSX) TD Cowen Conference presentation?
